ATLAS Score for Clostridium Difficile Infection
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- —0–2
- —3–6
The ATLAS Score for Clostridium Difficile Infection calculates predicting response to therapy in C. Key inputs include age 65 or older. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts response to therapy in C. diff patients
Clinical Indication
The ATLAS Score for Clostridium Difficile Infection is indicated for bedside clinical practice to support Predicts response to therapy in C. diff patients. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
Sum of points from: Age ≥65 (+1), Treatment with Systemic Antibiotics (+2), Leukocytosis >15,000/μL (+1), Albumin <2.5 g/dL (+1), Serum Creatinine >1.5× baseline (+1)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_65_or_older | boolean | Yes | Patient is 65 years of age or older |
| systemic_antibiotics | boolean | Yes | Patient is currently on systemic antibiotic therapy (other than for C. diff treatment) |
| leukocytosis | boolean | Yes | White blood cell count greater than 15,000 cells per microliter |
| low_albumin | boolean | Yes | Serum albumin level less than 2.5 g/dL (25 g/L) |
| elevated_creatinine | boolean | Yes | Serum creatinine level greater than 1.5 times the baseline/normal value |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | — | Good response to vancomycin therapy expected. Low risk of treatment failure. |
| 3–6 | — | Poor response to vancomycin therapy expected. High risk of treatment failure. |
Evidence-Based References (EBM)
- Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to vancomycin therapy. BMC Infect Dis. 2013;13:148.PMID: 23547790
- Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.PMID: 20307191